Delivery Order SPE2DB22D2214-SPE2DB26FS2JY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,287.10 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This non-set-aside, competitively awarded contract features firm fixed price terms with an ultimate completion date of September 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,784.59 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, issued on October 16, 2025, with completion expected by October 17, 2025, was awarded without set-aside restrictions through competitive procurement. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,800.52 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order was competitively awarded without set-aside designation and is set for completion by March 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune and inflammatory conditions. This firm fixed price delivery order, awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $32,216.41 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used to treat various inflammatory conditions. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, was competitively awarded without set-aside restrictions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $63,604.42 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency has awarded a delivery order valued at $4,531.80 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive set-aside contract. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a biologic medication used for treating autoimmune conditions. This competitively awarded, non-set-aside contract carries a ceiling value of $74,738.08 under a firm fixed-price arrangement, with a completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same...
- The Defense Logistics Agency awarded a $19,051.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. The award, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $5,543.70 to AmerisourceBergen Drug Corp for the supply of Humira Pen 40 mg/0.8 mls, a pharmaceutical product used to treat inflammatory conditions. This competitively awarded, firm fixed-price contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB26FS2JYDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $13,635.57 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work from its corporate office location in the same municipality. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The award demonstrates the company's continued role as a critical vendor within the federal medical supply chain and reflects DLA's strategy of leveraging prime vendor agreements to ensure reliable access to pharmaceutical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 10/15/25 |